Dr. Marc Bonaca discusses the VOYAGER PAD study, which showed the efficacy of rivaroxaban in lower extremity PAD. Dr. Eugenia Alleva discusses a study that found women with dysmenorrhea have increased cardiovascular risk. Dr. Benjamin Horne discusses a study that showed increases in PM2.5 during the summer and winter impact heart health. Dr. Ijeoma Eleazu talks about the harmful impact of cumulative stress on cardiovascular health. CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial. CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023. Dr. Christian Ruff on positive results from the AZALEA-TIMI 71 study of patients with AF at moderate to high risk of stroke. James K. Min, MD, founder and CEO of Cleerly, talks about improved screening for heart disease using a digital care platform. Dr. Babak Nazer discusses an experimental, leadless pacemaker that shows great potential in improving patient QoL. Drs. Jim List and Puneet Mohan discuss the Librexia program and the benefits of milvexian treatment. Dr. Karthik Gonuguntla discusses the study he led on cardiovascular health disparities in American Indian adults. Stenting improves chest pain, exercise capacity, and quality of life among patients with stable chest pain. A study indicates that blood transfusions for anemic patients hospitalized with heart attack may improve patient outcomes. Semaglutide reduced major CVD risk by 20% in adults with overweight or obesity, but not diabetes. COVID-19 infection increases the risk of thromboembolic events, particularly MI, in patients with prior MI. Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores. Individuals who use marijuana regularly may face an increased risk of heart failure, stroke, or heart attack. Young adults with prediabetes who persistently use tobacco have triple the risk of stroke. AI and deep learning models may be able to predict the risk of CVD events and valvular heart disease.